Compared with patients without AKI, patients with AKI were more likely to have longer ROSC time, higher epinephrine dosage, elevated lactate and CRP levels, and more frequent use of ECMO, shock, vasopressor, and inotropic agents. This evidence concerns the gene CRP and acute kidney injury.